Market revenue in 2020 | USD 77.9 million |
Market revenue in 2028 | USD 156.0 million |
Growth rate | 9.1% (CAGR from 2020 to 2028) |
Largest segment | Reagents |
Fastest growing segment | Equipment |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents, Equipment |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Qiagen NV, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Merck KGaA, Origin Enterprises PLC, MaxCyte Inc, PromoCell GmbH, Promega, Polyplus-transfection, Horizon Discovery |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transfection reagents & equipment market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 54.17% in 2020. Horizon Databook has segmented the Canada transfection reagents & equipment market based on reagents, equipment covering the revenue growth of each sub-segment from 2016 to 2028.
Canada transfection reagents and equipment market are expected to grow at considerable rate, owing to high incidence of chronic diseases in the country. According to HIV in Canada-Surveillance Report, Ontario, Quebec, Alberta, and British Columbia display higher incidence of infectious diseases such as HIV/AIDS.
Ongoing development and advancement initiatives taken by institutions such as Ontario University in novel reagents & methods are expected to drive market growth over the forecast period. Additionally, international companies operating in the market have set up operational facilities in Canada to increase accessibility of transfection products.
For instance, Miltenyi Biotec is a German transfection company that has an operational facility in Canada to offer the MACSelect 4 System, a transfected cell selection kit. This trend has contributed to the robust growth of Canada.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada transfection reagents & equipment market , including forecasts for subscribers. This country databook contains high-level insights into Canada transfection reagents & equipment market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account